Assessment of Sleep Disturbance in Alzheimer Disease
1 other identifier
interventional
70
1 country
1
Brief Summary
The purpose of this study is to study circadian rhythms, or daily cycles of sleep, wake, and activity. The investigators hope to learn how disturbed sleep in Alzheimer's Disease relates to changes in activity cycles, and how sleep disturbances may affect your daytime alertness. This project selects patients suffering from memory problems, or voluntary to be in our Control Group. There are three parts to this study: Sleep Diaries, Behavioral Questionnaire, and Activity Recordings
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable alzheimer-disease
Started Jul 2010
Shorter than P25 for not_applicable alzheimer-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2009
CompletedFirst Posted
Study publicly available on registry
January 28, 2009
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedMarch 31, 2026
March 1, 2026
1.3 years
January 27, 2009
March 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
assessment of apathy
at day 0, just after inclusion
Secondary Outcomes (2)
assessment of sleep disturbance
during a week, between day 0 and day 7
determine a genetic relationship between sleep disturbance and alzheimer disease
after all genetic analyses of the study
Study Arms (1)
1
OTHERBehavioral Questionnaire Sleep Recordings Genetic analysis
Interventions
Eligibility Criteria
You may qualify if:
- alzheimer disease
- MMSE \> 20
- over 65 years old
You may not qualify if:
- new psychotropic drug treatment
- patient unable to do neuropsychologic tests
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Mémoire de Ressources et de Recherche, CHU de Nice
Nice, 06000, France
Related Publications (1)
Ettore E, Bakardjian H, Sole M, Levy Nogueira M, Habert MO, Gabelle A, Dubois B, Robert P, David R. Relationships between objectives sleep parameters and brain amyloid load in subjects at risk for Alzheimer's disease: the INSIGHT-preAD Study. Sleep. 2019 Sep 6;42(9):zsz137. doi: 10.1093/sleep/zsz137.
PMID: 31267124RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe ROBERT
Centre Hospitalier Universitaire de Nice
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2009
First Posted
January 28, 2009
Study Start
July 1, 2010
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
March 31, 2026
Record last verified: 2026-03